The safety and efficacy of DAXXIFY is well established, with more than 20 years of research. In fact, DAXXIFY has been studied in the largest-ever phase 3 clinical trial conducted for a frown line treatment and included more than 2,800 people across different ages and with different skin types. DAXXIFY was studied in patients with varying skin types.